AIM AT MELANOMA (EIN 562427805) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2004

Legal Domicile

Principal Officer

SAMANTHA GUILD

Phone

9167060599

Tax Period

2024-01-01 to 2024-12-31

AIM AT MELANOMA, founded in 2004, is a community nonprofit in the Diseases & Disorders sector that reported $3.0M in total revenue in fiscal year 2024. Revenue decreased 8% compared to the prior year. The organization ran a surplus of $642K, a strong 22% operating margin.

Mission

TO SUPPORT MELANOMA RESEARCH; TO PROMOTE PREVENTION AND EDUCATION AMONG THE GENERAL PUBLIC AND MEDICAL PROFESSIONALS; AND TO PROVIDE COMPREHENSIVE AND EASILY ACCESSIBLE MELANOMA RESOURCES FOR PATIENTS, SURVIVORS, AND CAREGIVERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $2,750,295

Program Service Revenue $8,315

Investment Income $212,479

Other Revenue $0

TOTAL REVENUE $2,971,089

Expense Breakdown

Grants Paid $475,000

Salaries & Benefits $893,172

Fundraising Expenses $101,177

Program Expenses $2,075,335

Other Expenses $961,179

TOTAL EXPENSES $2,329,351

Year-over-Year Comparison

	2024	2023	Change
Revenue	$2,971,089	$3,245,381	-0.1%
Expenses	$2,329,351	$2,313,348	+0.0%
Net Income	$641,738	$932,033	-0.3%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$388,282

Total Directors

$228,274

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JOHN KIRKWOOD	DIRECTOR	3.00	Director	$0	$0	$0
MOHAMMED KASHANI-SABET	DIRECTOR	3.00	Director	$0	$0	$0
RENU GUPTA	DIRECTOR	1.00	Director	$0	$0	$0
HOWARD MAIBACH	DIRECTOR	1.00	Director	$0	$0	$0
SAMANTHA GUILD	PRESIDENT AND DIRECTOR	60.00	Officer Director	$204,500	$23,774	$228,274
ALICIA ROWELL	VICE PRESIDENT	40.00	Officer	$160,008	$0	$160,008

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$2,971,089	$2,329,351	$6,666,866	$641,738
2023	$3,245,381	$2,313,348	$6,023,375	$932,033
2022	$2,586,311	$2,194,738	$5,081,407	$391,573
2022	$2,586,311	$2,194,738	$5,081,407	$391,573
2021	$2,901,257	$1,842,198	$4,688,149	$1,059,059
2020	$2,335,060	$1,818,889	$3,672,755	$516,171
2019	$2,571,648	$2,037,762	$3,228,161	$533,886
2018	$2,544,308	$2,369,528	$2,573,532	$174,780

AIM AT MELANOMA